C3.ai Inc (AI) Stock Price Today
Aura AI Summary
Key Stats
- $1.52BMarket Cap
- -Volume
- TechnologySector
- $19.6652W High
- $7.7652W Low
- -Typical Hold Time
- $951.98MEnterprise Value
- -Div Yield
- -Trading Activity
Track C3.ai Inc (AI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, C3.ai Inc has traded between a low of $7.76 and a high of $19.66, highlighting its annual price range. Buy and sell C3.ai Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Most Recent News
Credit card balances overdue by 90 days have nearly doubled since 2022, while new delinquencies remain steady.
Since 2022, the amount of credit card debt that is 90 days overdue has almost doubled, indicating growing financial stress among borrowers. However, the rate of new delinquencies has not increased, suggesting that while existing overdue balances are ...
Class action lawsuit filed against Replimune over misleading FDA data submissions
Schall, Brown & Schwartz LLP announced a class action lawsuit against Replimune Group for allegedly making false and misleading statements about its Biologics License Application (BLA) to the FDA. The company reportedly submitted incomplete and unpla...
Class action lawsuit filed against Replimune over misleading FDA study claims
Replimune Group faces a class action lawsuit alleging violations of securities laws due to false and misleading statements about its FDA study design in its Biologics License Application. The lawsuit covers shareholders who bought Replimune shares be...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.